TOMM40 and Alzheimer disease: Given that mitochondrial dysfunction is a hallmark of AD pathology [73], reduced TOMM40 expression impairs mitochondrial integrity [74], leading to metabolic dysregulation, oxidative stress, and mitochondrial damage—processes closely linked to AD progression [75].